Mr. Speaker, our government has been working closely with experts and industry partners throughout this pandemic, which has allowed us to take an evidence-based approach to vaccine research and development. In the context of our continued research and evolving evidence, the National Research Council chose to implement the revised expert advice of the Vaccine Task Force and pursue other vaccine candidates. We will continue to actively pursue every promising option for a COVID-19 vaccine.
In the House of Commons on September 25th, 2020. See this statement in context.